Jane Patricia Gagliardi, MD

Associate Professor of Psychiatry and Behavioral Sciences
Associate Professor of Medicine
Campus mail 2213 Elba Street, Room 272; Box 3837, Durham, NC 27710
Phone (919) 684-2258

Jane P. Gagliardi, MD, MHS, FACP, FAPA completed medical school, residency training in combined internal medicine-psychiatry, and her masters of health science in the clinical research training program at Duke, where she has remained on faculty since completing residency training. Dr. Gagliardi has been involved in the educational programs in the Department of Medicine, where she served as Clerkship Director and Director of Undergraduate Medical Education for nearly a decade through June, 2014 and in the Department of Psychiatry and Behavioral Sciences, where she served as the Associate Program Director for the Psychiatry Residency Training Program from 2011 till 2013, when she assumed responsibility as the Director of the Psychiatry Residency Training Program.  She has been the Vice Chair for Education since 2014. She is a small group leader in the medical school Clinical Skills course and founded and co-directs the medical school Evidence-Based Medicine course. Dr. Gagliardi is particularly interested in the interplay between patient safety measures, various pressures in medicine including implementation of the electronic health record, and medical education, and she has worked to develop and encourage projects in patient safety and quality improvement. She does inpatient clinical work in both departments, spending time on the General Medicine, inpatient Psychiatry, combined Medicine-Psychiatry, Consultation-Liaison Psychiatry, and Emergency Psychiatry services.

Education and Training

  • Resident, Psychiatry, Duke University, 1998 - 2003
  • M.D., Duke University, 1998

Publications

Atomoxetine (Strattera) revisited..” Med Lett Drugs Ther 46, no. 1189 (August 16, 2004).

PMID
15314585
Scholars@Duke

Do NSAIDs interfere with the cardioprotective effects of aspirin?.” Med Lett Drugs Ther 46, no. 1188 (August 2, 2004): 61–62.

PMID
15289743
Scholars@Duke

Performance-enhancing drugs..” Med Lett Drugs Ther 46, no. 1187 (July 19, 2004): 57–59.

PMID
15263874
Scholars@Duke

Conductive keratoplasty (CK) for presbyopia..” Med Lett Drugs Ther 46, no. 1185 (June 21, 2004): 49–50.

PMID
15211287
Scholars@Duke

Prevention and treatment of sunburn..” Med Lett Drugs Ther 46, no. 1184 (June 7, 2004): 45–46.

PMID
15184807
Scholars@Duke

Tiotropium (Spiriva) for COPD..” Med Lett Drugs Ther 46, no. 1183 (May 24, 2004): 41–42.

PMID
15159658
Scholars@Duke

Cholesterol rethink for high-risk patients..” Med Lett Drugs Ther 46, no. 1182 (May 10, 2004): 37–39.

PMID
15136771
Scholars@Duke

NovoSeven for non-hemophilia hemostasis..” Med Lett Drugs Ther 46, no. 1181 (April 26, 2004): 33–34.

PMID
15114252
Scholars@Duke

Gagliardi, Jane P., and K Ranga Rama Krishnan. “Evidence-based mental health use of anticonvulsants during pregnancy..” Psychopharmacology Bulletin 37, no. 2 (January 2003): 59–66.

PMID
14566215
Scholars@Duke

Gagliardi, Jane P., and Ranga R. Krishnan. “Evidence for the treatment of borderline personality disorder..” Psychopharmacol Bull 37, no. 1 (2003): 30–46.

PMID
14561947
Scholars@Duke

Pages